Pursuant to Regulation 30(6) of the Listing Regulations, Metropolis Healthcare has enclosed the schedule for the Analyst / Institutional Investor Meeting to be held at Metropolis Global Reference Laboratory, Kurla. This will commence with a lab tour, followed by the investor meeting on June 05, 2025, as per the details enclosed. The above intimation is also available on the website of the Company i.e. www.metropolisindia.com
The above information is a part of company’s filings submitted to BSE.
